Table 6 Changes in healthy (balanced), sub-healthy, and disease (unbalanced) BCs in participants within corresponding subgroups upon CM treatment and at follow-up
From: Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study
(A) Participants with particular CM syndromes | ||||
|---|---|---|---|---|
% among group | Baseline (V1) | After CM treatment (V4) | After CM treatment (V7) | Follow-up (V8) |
Disease | 80.77 | 82.93 | 81.54 | 82 |
Sub-healthy | 8.65 | 3.66 | 7.69 | 8 |
Healthy | 10.58 | 13.41 | 10.77 | 10 |
(B) Participants without particular CM syndromes | ||||
|---|---|---|---|---|
% among group | Baseline (V1) | After CM treatment (V4) | After CM treatment (V7) | Follow-up (V8) |
Disease | 78.95 | 65.96 | 59.09 | 68.85 |
Sub-healthy | 18.42 | 17.02 | 18.18 | 16.39 |
Healthy | 2.63 | 17.02 | 22.73 | 14.75 |